Processa Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Vero Beach, FL
PCSA chart
What traders are saying about $PCSA
Latest postsProcessa Pharmaceuticals, Inc. news
- Processa Pharmaceuticals, Inc. SEC Filing (Oct 26, 2026)
Stock Titan ·
- Processa Pharmaceuticals, Inc. Estimates – NASDAQ:PCSA
TradingView ·
- Form DEF 14A Processa Pharmaceuticals Inc For: 22 October By Investing.com
Investing.com India ·
- PCSA Q3'26 Earnings: EPS estimate is (1.00) USD
TradingView ·
- Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- Processa Pharmaceuticals Acquires Vidya Therapeutics and Secures $200 Million Financing to Advance BTK Inhibitor Pipeline
investorshub.advfn.com ·
- PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
Yahoo Finance ·
- Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
Yahoo Finance ·
- Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Yahoo Finance ·
- Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
Yahoo Finance ·
- Wall Street Set to Open Higher Thursday as Inflation Rises Less Than Expected; Jobless Claims Decline
Yahoo Finance ·
- Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
Yahoo Finance ·
Processa Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | $0 |
| Net income | -$13.6M | -$11.8M | -$11.1M | -$27.4M |
| Diluted EPS | $-10.36 | $-96.78 | $-8.48 | $-34.05 |
| Total assets (year end) | $7.8M | $3.2M | $5.8M | $8.6M |
| Cash and equivalents (year end) | $5.5M | $1.2M | $4.7M | $6.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Processa Pharmaceuticals, Inc.
- Ticker
- PCSA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Vero Beach, FL
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1533743
- Former names
- Heatwurx, Inc.
Frequently asked questions
What exchange is Processa Pharmaceuticals, Inc. listed on?
Processa Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol PCSA.
What industry is Processa Pharmaceuticals, Inc. in?
Processa Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Processa Pharmaceuticals, Inc. headquartered?
Processa Pharmaceuticals, Inc.'s business address on file with the SEC is in Vero Beach, FL.
When does Processa Pharmaceuticals, Inc.'s fiscal year end?
Processa Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Processa Pharmaceuticals, Inc. report?
Processa Pharmaceuticals, Inc. reported $0 in revenue for calendar year 2022, according to its SEC filings.